Medium severity6.1NVD Advisory· Published May 19, 2021· Updated Jul 9, 2026
CVE-2017-17678
CVE-2017-17678
Description
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
AI Insight
LLM-synthesized narrative grounded in this CVE's description and references.
Affected products
3cpe:2.3:a:bmc:remedy_mid-tier:9.1:sp3:*:*:*:*:*:*+ 1 more
- cpe:2.3:a:bmc:remedy_mid-tier:9.1:sp3:*:*:*:*:*:*
- (no CPE)range: = 9.1SP3
- BMC/BMC Remedy Mid Tierdescription
Patches
Vulnerability mechanics
References
2- docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.htmlnvdRelease NotesVendor Advisory
- seclists.org/fulldisclosure/2017/Oct/52nvdMailing ListThird Party Advisory
News mentions
0No linked articles in our index yet.